Last week in Utrecht, we joined the partners of the KeratOPrinter project at the 2nd Update Meeting, hosted by UMC Utrecht, to discuss the latest advances in the development of a 3D bioprinted corneal cell therapy.
ASPHALION, a proud regulatory partner in KeratOPrinter, was represented by Diego Sanoja (ASPHALION MedTech) and Jon Giblin, who presented the regulatory roadmap for the development and discussed regulatory strategy.
The meeting was packed with scientific and technological progress from all work packages, with partners presenting their latest advances, and alignment on the next steps to advance the development of the therapy was reached.
A big thank you to UMC Utrecht for their hospitality and for hosting an exciting and dynamic meeting.
Need more information about this or other EU-funded projects? Contact us! [email protected]







